Topic 379: DigiBioMarC: Digital BioMarkers for Clinical Impact - Moonshot

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 75N91018C00010-0-0-0
Agency Tracking Number: N43CA180010
Amount: $224,294.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NCI
Solicitation Number: N/A
Timeline
Solicitation Year: 2017
Award Year: 2018
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
525 University Avenue, PALO ALTO, CA, 94301
DUNS: 078739184
HUBZone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 Michelle Longmire
 (505) 463-8394
 michelle@Medable.com
Business Contact
 Michelle Longmire
Phone: (505) 463-8394
Email: michelle@Medable.com
Research Institution
N/A
Abstract
The overall objective of this Fast-Track SBIR contract project is to develop DigiBioMarCTM (Digital BioMarkers for Clinical Impact), a scalable and flexible cloud-based platform to capture and analyze wearable, implantable, or external device data. This platform also provides an informatics tool for automated data aggregation, integration, and machine learning algorithms. It is based on the scalable user-centered Medable platform, which implements standardization and normalization of patient-generated data to drive health insights. DigiBioMarCTM will compare and combine disparate data streams to understand contextualized patient physiology in real time in order to identify disease and/or detect changes in disease/health status. It also will support cohort and clinical studies, particularly those testing digital biomarkers from wearable sensor technologies. This Fast-Track project will focus on product development with an ultimate aim of a product that improves cancer research data and clinical trials, enhances clinical care, and that can be used to engage patients in preventive health behaviors and treatment adherence. The Phase I goal is to develop a data-agnostic DigiBioMarCTM prototype for validation in Phase II. The Phase 1 Go/No-Go decision point to proceed to Phase II will be a working prototype with specified features for further development and validation in Phase II.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government